MB "Molecule projects" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
846,260 |
- |
114,986 |
97,609 |
- |
0.09 |
3.31 |
20.33 |
11.53 |
97,709 |
323,362 |
25,488 |
395,583 |
2024 |
---|
470,006 |
- |
30,307 |
25,671 |
- |
0.07 |
1.44 |
26.52 |
5.46 |
49,472 |
71,326 |
35,788 |
85,010 |
Register and
explore Okredo data2024 |
---|
470,006 |
- |
30,307 |
25,671 |
- |
0.07 |
1.44 |
26.52 |
5.46 |
49,472 |
71,326 |
35,788 |
85,010 |
Register and
explore Okredo data2024
Turnover (€)
470,006 €-44 % *
Sales per employee (€)
-Profit before tax (€)
30,307 €-74 % *
Net Profit (€)
25,671 €-74 % *
Profit per employee (€)
-Working capital requirement
0.07 -22.22 % *
Debt-to-equity ratio
1.44 -56.50 % *
Total profitability (%)
26.52 %30.45 % *
Net profitability (%)
5.46 %-52.65 % *
Equity (€)
49,472 €-49 % *
Amounts Payable And Liabilities (€)
71,326 €-78 % *
Non-current Assets (€)
35,788 €40 % *
CurrentAssets (€)
85,010 €-79 % *